Skip to main content
. 2022 Mar 30;13(4):620. doi: 10.3390/genes13040620

Table 1.

Basic clinical characteristics of patients in the TCGA cohort and E-MTAB-1980 cohort.

TCGA Cohort (526) E-MTAB-1980 Cohort (101)
Age (years)
  ≥65 194 (36.9%) 44 (43.6%)
  <65 332 (63.1%) 57 (56.4%)
Sex
  Male 343 (65.2%) 77 (23.8%)
  Female 183 (34.8%) 24 (23.8%
Grade
  G1 13 (2.5%) 13 (12.9%)
  G2 224 (42.6%) 59 (58.4%)
  G3 204 (38.8%) 22 (21.8%)
  G4 74 (14.1%) 5 (5.0%)
  Unknown 8 (1.5%) 2 (2.0%)
Stage
  I 261 (49.6%) 67 (66.3%)
  II 57 (10.8%) 11 (10.9%)
  III 125 (23.8%) 14 (13.9%)
  IV 83 (15.8%) 13 (12.9%)
T stage
  T1 267 (50.8%) 68 (67.3%)
  T2 69 (13.1%) 11 (10.9%)
  T3 179 (34.0%) 21 (20.85)
  T4 11 (2.1%) 1 (1.0%)
N stage
  N2 \ 4 (4%)
  N1 16 (3.1%) 3 (3.0%)
  N0 238 (45.2%) 94 (93.1%)
  Unknown 272 (51.7%) /
M stage
  M1 78 (14.8%) 12 (11.9%)
  M0 418 (79.5%) 89 (88.1%)
  Unknown 30 (5.7%) /
Survival
  Dead 171 (32.5%) 23 (22.8%)
  Living 355 (67.5%) 78 (77.25)